Literature DB >> 22042859

Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport.

Yu Bai1, Lilin Ye, Devin B Tesar, Haichen Song, Deming Zhao, Pamela J Björkman, Derry C Roopenian, Xiaoping Zhu.   

Abstract

IgG was traditionally thought to neutralize virions by blocking their attachment to or penetration into mucosal epithelial cells, a common site of exposure to viruses. However, we describe an intracellular neutralizing action for an influenza hemagglutinin-specific monoclonal antibody, Y8-10C2 (Y8), which has neutralizing activity only at an acidic pH. When Y8 was applied to the basolateral surface of Madin-Darby canine kidney cells expressing the rat neonatal Fc receptor for IgG (FcRn), it significantly reduced viral replication following apical exposure of the cell monolayer to influenza virus. Virus neutralization by Y8 mAb was dependent on FcRn expression and its transport of IgG. As both FcRn and Y8 mAb bind their partners only at acidic pH, the Y8 mAb is proposed to carry out its antiviral activity intracellularly. Furthermore, the virus, Y8 mAb, and FcRn colocalized within endosomes, possibly inhibiting the fusion of viral envelopes with endosomal membranes during primary uncoating, and preventing the accumulation of the neutralized viral nucleoprotein antigen in the nucleus. Prophylactic administration of Y8 mAb before viral challenge in WT mice, but not FcRn-KO mice, conferred protection from lethality, prevented weight loss, resulted in a significant reduction in pulmonary virus titers, and largely reduced virus-induced lung pathology. Thus, this study reveals an intracellular mechanism for viral neutralization in polarized epithelial cells that is dependent on FcRn-mediated transport of neutralizing IgG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042859      PMCID: PMC3215070          DOI: 10.1073/pnas.1115348108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

3.  Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.

Authors:  T Bächi; W Gerhard; J W Yewdell
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.

Authors:  Zili Li; Senthilkumar Palaniyandi; Rongyu Zeng; Wenbin Tuo; Derry C Roopenian; Xiaoping Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

5.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants.

Authors:  M Raghavan; V R Bonagura; S L Morrison; P J Bjorkman
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

7.  Visualization of microtubule-mediated transport of influenza viral progeny ribonucleoprotein.

Authors:  Fumitaka Momose; Yuji Kikuchi; Katsuhiro Komase; Yuko Morikawa
Journal:  Microbes Infect       Date:  2007-07-21       Impact factor: 2.700

8.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

9.  Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor.

Authors:  Devin B Tesar; Noreen E Tiangco; Pamela J Bjorkman
Journal:  Traffic       Date:  2006-09       Impact factor: 6.215

10.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.

Authors:  T Danieli; S L Pelletier; Y I Henis; J M White
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

View more
  40 in total

Review 1.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

2.  Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants.

Authors:  Carl T D'Angio; Claire P Wyman; Ravi S Misra; Jessica L Halliley; Hongyue Wang; Julianne E Hunn; Caitlin M Fallone; F Eun-Hyung Lee
Journal:  Vaccine       Date:  2017-08-12       Impact factor: 3.641

3.  Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Richard S Blumberg; Kenneth W Beagley
Journal:  Immunol Cell Biol       Date:  2014-01-21       Impact factor: 5.126

Review 4.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

5.  Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.

Authors:  Qingsheng Li; Ming Zeng; Lijie Duan; James E Voss; Anthony J Smith; Stefan Pambuccian; Liang Shang; Stephen Wietgrefe; Peter J Southern; Cavan S Reilly; Pamela J Skinner; Mary L Zupancic; John V Carlis; Michael Piatak; Diane Waterman; R Keith Reeves; Katherine Masek-Hammerman; Cynthia A Derdeyn; Michael D Alpert; David T Evans; Heinz Kohler; Sybille Müller; James Robinson; Jeffrey D Lifson; Dennis R Burton; R Paul Johnson; Ashley T Haase
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

Review 6.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

7.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15

8.  Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs.

Authors:  Christopher W Seibert; Saad Rahmat; Jens C Krause; Dirk Eggink; Randy A Albrecht; Peter H Goff; Florian Krammer; J Andrew Duty; Nicole M Bouvier; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

9.  Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.

Authors:  Yumay Chen; Alex Chernyavsky; Robert J Webber; Sergei A Grando; Ping H Wang
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

10.  Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Odilia L Wijburg; Kenneth W Beagley
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.